Quick answer: latest quarter results, by ticker or company name

Safilo Group SpA (0NJ5.L) Q4 2025 Earnings Report

Comprehensive analysis of Safilo Group SpA's financial performance for Q4 2025 with historical comparisons and future outlook.

Reported Q: Q4 2025 Rev YoY: +93.3% EPS YoY: +186.0% Move: -0.89%
Safilo Group SpA
0NJ5.L
€1.673 -0.89%
Exchange LSE Sector Healthcare Industry Medical Instruments Supplies
Q4 2025
Published: Dec 31, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 0NJ5.L

Reported

Report Date

Dec 31, 2025

Quarter Q4 2025

Revenue

445.75M

YoY: +93.3%

EPS

0.02

YoY: +186.0%

Market Move

-0.89%

Previous quarter: Q2 2025

Follow this company to get upcoming quarter alerts automatically.

Sign In To Follow

Earnings Highlights

  • Revenue of $445.75M up 93.3% year-over-year
  • EPS of $0.02 increased by 186% from previous year
  • Gross margin of 60.8%
  • Net income of 7.36M
  • "" -
0NJ5.L
Company 0NJ5.L
Period Q4 2025
Currency EUR
Report Type Quarterly Earnings
Generated Mar 30, 2026

Swipe to view all report sections

Executive Summary

Safilo Group SpA reported Q4 2025 revenue of €445.8 million, down modestly year-over-year and down about 17% quarter-over-quarter, reflecting a seasonally weaker Q4 and ongoing demand normalization across key markets. Gross profit totaled €271.1 million with a solid gross margin of 60.8%, underscoring the durability of Safilo’s branded and licensed product mix despite top-line softness. Operating income remained negative at €1.2 million for the quarter, with EBITDA at a similar negative level, signaling ongoing cost absorption and the impact of softer volumes on operating leverage. Net income was €7.4 million for the quarter, delivering a positive bottom line despite the near-term profitability headwinds, supported by other income and cost controls.

Key Performance Indicators

Revenue
Increasing
445.75M
QoQ: -17.09% | YoY: 93.28%
Gross Profit
Increasing
271.05M
60.81% margin
QoQ: -17.42% | YoY: 98.14%
Operating Income
Decreasing
-1.21M
QoQ: -102.37% | YoY: -127.54%
Net Income
Increasing
7.36M
QoQ: -82.35% | YoY: 213.94%
EPS
Increasing
0.02
QoQ: -83.80% | YoY: 185.96%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 445.75 0.02 +93.3% View
Q2 2025 268.81 0.05 +133.1% View
Q1 2025 268.81 0.05 +1.1% View
Q4 2024 461.26 0.01 -2.8% View
Q3 2024 230.63 0.01 -2.8% View
Sign In To Follow Alerts

More 0NJ5.L Quarterly Reports

0NJ5.L

Safilo Group SpA
Q2 2025 Report
Safilo Group S.p.A. QQ2 2025 Results — Healthcare (Medical - Instruments & Supplies): Robust Revenue Growth, Margin Resilience and Prudent Balance S...
Read full report

0NJ5.L

Safilo Group SpA
Q1 2025 Report
Safilo Group S.p.A. QQ1 2025 Results: Revenue EUR 268.8m, Margin Resilience Across a Seasonally Tough Quarter...
Read full report

0NJ5.L

Safilo Group SpA
Q4 2024 Report
Safilo Group S.p.A. (0NJ5.L) QQ4 2024 Results – Revenue Rebound, Margin Management and Solid Free Cash Flow in Healthcare Eyewear...
Read full report

0NJ5.L

Safilo Group SpA
Q3 2024 Report
Safilo Group S.p.A. (0NJ5.L) Q3 2024 Results - Modest Margin Resilience Amid Sharp QoQ Revenue Contraction in Healthcare Eyewear...
Read full report

Related Financial Data

Sector Analysis: Healthcare

View more companies and financial data in the Healthcare sector.

Explore Sector

0NJ5.L Full Profile

View complete financial profile, news, and analysis for Safilo Group SpA.

Company Profile

0NJ5.L Financial Statements

Access detailed balance sheets, income statements, and cash flow reports.

View Financials

Earnings Calendar

Stay updated with upcoming earnings announcements from all public companies.

View Calendar